Literature DB >> 12003724

Atheroembolism.

John S. Smyth1, John E. Scoble.   

Abstract

The many manifestations of atheroembolism are apparent in all specialties. However, with increasing intervention in older patients with atherosclerotic disease, it has become an important renal clinical problem. Atheroembolic disease is widely recognized as a cause of acute catastrophic renal dysfunction and recent important data have suggested that effective management protocols can improve outcome. It is probable that the clinical course is insidious in the majority of patients with severe atherosclerotic aortic disease. The management of these patients is less clear and at present rests on small anecdotal reports.

Entities:  

Year:  2002        PMID: 12003724     DOI: 10.1007/s11936-002-0006-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  30 in total

Review 1.  The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases.

Authors:  M Hasegawa; S Kawashima; M Shikano; H Hasegawa; M Tomita; K Murakami; H Kushimoto; H Katsumata; T Toba; A Oohashi; S Hiramitsu; K Matsunaga
Journal:  Am J Nephrol       Date:  2000 Jul-Aug       Impact factor: 3.754

2.  LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism.

Authors:  S Tsunoda; S Daimon; R Miyazaki; H Fujii; A Inazu; H Mabuchi
Journal:  Nephrol Dial Transplant       Date:  1999-04       Impact factor: 5.992

Review 3.  Cholesterol emboli: a common cause of renal failure.

Authors:  D G Vidt
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

4.  Cholesterol crystal embolization in the Netherlands.

Authors:  W Moolenaar; C B Lamers
Journal:  Arch Intern Med       Date:  1996-03-25

5.  Control of cholesterol embolization by discontinuation of anticoagulant therapy.

Authors:  F J Bruns; D P Segel; S Adler
Journal:  Am J Med Sci       Date:  1978 Jan-Feb       Impact factor: 2.378

6.  Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Authors:  L A Prosser; A A Stinnett; P A Goldman; L W Williams; M G Hunink; L Goldman; M C Weinstein
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

7.  Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography.

Authors:  P Vaduganathan; A Ewton; S F Nagueh; D G Weilbaecher; H J Safi; W A Zoghbi
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

8.  Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.

Authors:  M Haas; B H Spargo; E J Wit; S M Meehan
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

9.  Indications for low-density lipoprotein apheresis.

Authors:  B R Gordon; E Stein; P Jones; D R Illingworth
Journal:  Am J Cardiol       Date:  1994-12-01       Impact factor: 2.778

Review 10.  Renal cholesterol embolic disease. Case report and review of the literature.

Authors:  W C Lye; J S Cheah; R Sinniah
Journal:  Am J Nephrol       Date:  1993       Impact factor: 3.754

View more
  2 in total

Review 1.  Ultrasound and color Doppler applications in chronic kidney disease.

Authors:  Ilaria Petrucci; Anna Clementi; Concetto Sessa; Irene Torrisi; Mario Meola
Journal:  J Nephrol       Date:  2018-09-06       Impact factor: 3.902

2.  Color Doppler sonography in the study of chronic ischemic nephropathy.

Authors:  M Meola; I Petrucci
Journal:  J Ultrasound       Date:  2008-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.